COVID-19 (novel coronavirus)

COVID-19 Masks

Photo by Macau Photo Agency on Unsplash

A pneumonia of unknown cause detected in Wuhan, China was first reported to the World Health Organization (WHO) Country Office in China on 31 December 2019.

The outbreak was declared a Public Health Emergency of International Concern on 30 January 2020. On 11 February 2020, WHO announced a name for the new coronavirus disease: COVID-19

Symptoms range from a mild cough to pneumonia. Some people recover easily, others may get very sick very quickly.

The Victorian State Government has provided AUD$6 million to Peter Doherty Institute for Infection and Immunity (Doherty Institute) and Burnet Institute expedite development of new therapeutics, diagnostics, clinical research and the public health response to the novel coronavirus, known as COVID-19.

Watch the video below or view the news story for more information.

Projects

Current Projects

  • ACE2 inhibitors for treatment of COVID-19

  • Age-related immune dysfunction may underpin poor COVID-19 outcomes in the elderly

  • Antenatal and postnatal care remote contacts guidance

  • Anti-COVID-19 biological drugs for prevention and treatment

  • Coping with COVID-19: Young people’s health and wellbeing in Australia

  • COVASIM: Modelling COVID-19

  • COVID-19 antigens for PoC test development

  • COVID-19 Healthcare E-Learning Platform (CoHELP)

  • COVID-19 Journey Project

  • COVID-19 Vaccine Development

  • Experiences of receiving or providing maternity care during CoVID-19 pandemic: The CovMat Study

  • Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

  • Mapping of COVID-19-related pregnancy and perinatal research in Australia

  • National COVID-19 Clinical Evidence Taskforce

  • Neutralising antibody assays for COVID-19

  • Optimising Quarantine Study

  • Rapid review of maternal health recommendations related to the COVID-19 pandemic

  • SCOOP: Strengthening COVID-19 Communication in Pregnancy

  • STRIVE PNG: Stronger Surveillance and Systems Support for Rapid Identification and Containment of Resurgent or Resistant Vector-Borne Pathogens in Papua New Guinea

  • SuperMIX: The Melbourne Injecting Drug User Cohort Study

  • The Optimise Study: Optimising Isolation, Quarantine and Distancing for COVID-19